Shukra Pharmaceuticals standalone net profit declines 42.86% in the June 2018 quarter

Sales rise 3.96% to Rs 1.05 crore

Net profit of Shukra Pharmaceuticals declined 42.86% to Rs 0.04 crore in the quarter ended June 2018 as against Rs 0.07 crore during the previous quarter ended June 2017. Sales rose 3.96% to Rs 1.05 crore in the quarter ended June 2018 as against Rs 1.01 crore during the previous quarter ended June 2017. ParticularsQuarter EndedJun. 2018Jun. 2017% Var.Sales1.051.01 4 OPM %33.3320.79 -PBDT0.380.23 65 PBT0.200.10 100 NP0.040.07 -43

Powered by Capital Market - Live News